Drug Shortage Report for TEVA-CEFADROXIL
Report ID | 143716 |
Drug Identification Number | 02235134 |
Brand name | TEVA-CEFADROXIL |
Common or Proper name | CEFADROXIL 500MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEFADROXIL |
Strength(s) | 500MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | J01DB |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-08-04 |
Estimated end date | 2021-11-30 |
Actual end date | 2021-11-30 |
Shortage status | Resolved |
Updated date | 2021-12-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2021-12-02 | French | Compare |
v9 | 2021-12-02 | English | Compare |
v8 | 2021-11-04 | French | Compare |
v7 | 2021-11-04 | English | Compare |
v6 | 2021-10-07 | French | Compare |
v5 | 2021-10-07 | English | Compare |
v4 | 2021-08-27 | French | Compare |
v3 | 2021-08-27 | English | Compare |
v2 | 2021-08-05 | French | Compare |
v1 | 2021-08-05 | English | Compare |
Showing 1 to 10 of 10